BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15258776)

  • 1. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.
    Gelisken F; Inhoffen W; Hermann A; Grisanti S; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):926-30. PubMed ID: 15258776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hara W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2008 Mar; 145(3):518-526. PubMed ID: 18207125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge of chorioretinal atrophy in pathologic myopia.
    Pece A; Milani P; Isola V; Pierro L
    Ophthalmologica; 2011; 225(3):161-8. PubMed ID: 21212705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
    Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
    Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
    Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
    Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.
    Maár N; Ergun E; Luksch A; Stur M
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1262-6. PubMed ID: 16538450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.
    Parmeggiani F; Gemmati D; Costagliola C; Semeraro F; D'Angelo S; Perri P; Sebastiani A; Incorvaia C
    Ophthalmology; 2010 Mar; 117(3):517-23. PubMed ID: 20044141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
    Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
    Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
    Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
    Ergun E; Heinzl H; Stur M
    Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.
    Potter MJ; Szabo SM; Ho T
    Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):639-41. PubMed ID: 16175378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV.
    Wachtlin J; Stroux A; Wehner A; Heimann H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):438-45. PubMed ID: 15672299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one year results).
    Hussain N; Das T; Vashist U; Sumashri K
    Indian J Ophthalmol; 2004 Sep; 52(3):227-31. PubMed ID: 15510463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.